Epidemiology of gout and chondrocalcinosis
Abstract Views: 1045
PDF: 1453
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- L. Andreoli, F. Pregnolato, R.W. Burlingame, V. Fanelli, F. Allegri, A. Radice, C. Corace, R.A. Sinico, A. Tinconi, P.L. Meroni, Primary antiphospholipid syndrome evolving into systemic lupus erythematosus: may antinucleosome antibodies be predictive? , Reumatismo: Vol. 60 No. 3 (2008)
- C. Giannitti, G. Morozzi, S. D'Alfonso, F. Bellisai, M. Galeazzi, Viral genotype and HLA class II alleles influence on extra-hepatic manifestations of chronic HCV infection , Reumatismo: Vol. 60 No. 3 (2008)
You may also start an advanced similarity search for this article.